Want to see TXG full AI Analyst Report?
Compare 10x Genomics (TXG) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| TXG10x Genomics | $70.11 | $9.13B | -118.83 | 463.59% | Moderate Buy | TXG | ||||
| TECHBio-Techne | $72.66 | $11.41B | 62.10 | 19.19% | Moderate Sell | TXG vs TECH | ||||
| TWSTTwist Bioscience | $152.78 | $10.06B | -68.82 | 390.15% | Moderate Buy | TXG vs TWST | ||||
| ADPTAdaptive Biotechnologies | $26.64 | $4.25B | -65.39 | 57.54% | Strong Buy | TXG vs ADPT | ||||
| MRVIMaravai Lifesciences Holdings | $7.81 | $2.03B | -14.58 | 148.73% | Moderate Buy | TXG vs MRVI | ||||
| ALMRAlamar Biosciences, Inc. | $30.60 | $2.12B | -57.73 | 39.09% | Moderate Buy | TXG vs ALMR |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| TXG | 10x Genomics | 70.11 | 56.41 | 411.75% | |
| TECH | Bio-Techne | 72.66 | 11.75 | 19.28% | |
| TWST | Twist Bioscience | 152.78 | 121.21 | 383.94% | |
| ADPT | Adaptive Biotechnologies | 26.64 | 9.30 | 53.63% | |
| MRVI | Maravai Lifesciences Holdings | 7.81 | 4.87 | 165.65% | |
| ALMR | Alamar Biosciences, Inc. | 30.60 | 8.60 | 39.09% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts